Symptoms from rhinitis can be assessed to be more troubling to trie patient than symptoms from asthma. Further, the array of bioactivc mediators, cytokines, and cells in nasal mucosa suggests that rhinitis is a much more complex condition than formerly thought. The presence of allergic rhinitis is a risk factor for emergence of asthma. Topical nasal corticosteroids have a relatively flat dose-response curve and have onset of action within one to two days for some patients. Allergen immunotherapy remains the only immunomodulator for patients with allergic rhinitis, with the possible exception of long-term administration of nasal corticosteroids, Author.
|Original language||English (US)|
|Number of pages||1|
|Journal||Journal of Laryngology and Otology|
|State||Published - Dec 1 1998|
ASJC Scopus subject areas